These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7046 related articles for article (PubMed ID: 22304773)
1. [Antitumoral efficacy by systemic delivery of cationic liposome-plasmid interleukin-15 complexes in murine models of lung metastasis]. Teng X; Zhou XK; Zhang YB; Qiu J; Mao YQ; Deng HX; Li J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Feb; 28(2):148-52. PubMed ID: 22304773 [TBL] [Abstract][Full Text] [Related]
2. IL15 combined with Caspy2 provides enhanced therapeutic efficiency against murine malignant neoplasm growth and metastasis. Yang Y; Zhang XM; Zhang N; Cheng L; Li C; Zhang S; Zhang JF; Dai L; Tian HW; Yan N; Fan P; Dai LX; Xu F; Shi G; Chen XL; Du T; Li YM; Wei YQ; Deng HX Cancer Gene Ther; 2012 Jul; 19(7):460-7. PubMed ID: 22539063 [TBL] [Abstract][Full Text] [Related]
3. Antitumoral efficacy by systemic delivery of heparin conjugated polyethylenimine-plasmid interleukin-15 complexes in murine models of lung metastasis. Zhou X; Li X; Gou M; Qiu J; Li J; Yu C; Zhang Y; Zhang N; Teng X; Chen Z; Luo C; Wang Z; Liu X; Shen G; Yang L; Qian Z; Wei Y; Li J Cancer Sci; 2011 Jul; 102(7):1403-9. PubMed ID: 21564417 [TBL] [Abstract][Full Text] [Related]
4. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases. Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534 [TBL] [Abstract][Full Text] [Related]
5. [Combination therapy of experimental murine hepatoma with mIL-12 gene and MHC I gene mediated by liposome]. Wang KM; Xia AD; Chen SS Ai Zheng; 2002 Oct; 21(10):1041-6. PubMed ID: 12508639 [TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA. Nosrati M; Li S; Bagheri S; Ginzinger D; Blackburn EH; Debs RJ; Kashani-Sabet M Clin Cancer Res; 2004 Aug; 10(15):4983-90. PubMed ID: 15297398 [TBL] [Abstract][Full Text] [Related]
7. Cationic liposomes with plasmid DNA influence cancer metastatic capability. Ota T; Maeda M; Tatsuka M Anticancer Res; 2002; 22(6C):4049-52. PubMed ID: 12553031 [TBL] [Abstract][Full Text] [Related]
8. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex. Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752 [TBL] [Abstract][Full Text] [Related]
9. Enhanced growth inhibition of metastatic lung tumors by intravenous injection of ATRA-cationic liposome/IL-12 pDNA complexes in mice. Charoensit P; Kawakami S; Higuchi Y; Yamashita F; Hashida M Cancer Gene Ther; 2010 Jul; 17(7):512-22. PubMed ID: 20414324 [TBL] [Abstract][Full Text] [Related]
10. Novel cationic liposomes provide highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets. Markov OO; Mironova NL; Maslov MA; Petukhov IA; Morozova NG; Vlassov VV; Zenkova MA J Control Release; 2012 Jun; 160(2):200-10. PubMed ID: 22155599 [TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin. Gautam A; Waldrep JC; Densmore CL; Koshkina N; Melton S; Roberts L; Gilbert B; Knight V Gene Ther; 2002 Mar; 9(5):353-7. PubMed ID: 11938455 [TBL] [Abstract][Full Text] [Related]
12. Plasmid DNA-induced cytokines together with cyclophosphamide decrease size and number of melanoma lung metastases. Cichon T; Smolarczyk R; Sochanik A; Szala S Anticancer Res; 2006; 26(3A):2033-6. PubMed ID: 16827141 [TBL] [Abstract][Full Text] [Related]
13. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation. Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491 [TBL] [Abstract][Full Text] [Related]
14. Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo. Parker SE; Khatibi S; Margalith M; Anderson D; Yankauckas M; Gromkowski SH; Latimer T; Lew D; Marquet M; Manthorpe M; Hobart P; Hersh E; Stopeck AT; Norman J Cancer Gene Ther; 1996; 3(3):175-85. PubMed ID: 8725882 [TBL] [Abstract][Full Text] [Related]
15. [Antitumor and antimetastatic activities of plasmid pcDNA3. 1-IP10 complexed with cationic liposome in mice with 4T1 breast cancer]. Tang QQ; Shi W; Lü HM; Peng XC; Wen YJ Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):195-8. PubMed ID: 19462888 [TBL] [Abstract][Full Text] [Related]
16. Characterization of interleukin-15 gene-modified human natural killer cells: implications for adoptive cellular immunotherapy. Zhang J; Sun R; Wei H; Zhang J; Tian Z Haematologica; 2004 Mar; 89(3):338-47. PubMed ID: 15020274 [TBL] [Abstract][Full Text] [Related]
17. Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer. Zou Y; Zong G; Ling YH; Perez-Soler R Cancer Gene Ther; 2000 May; 7(5):683-96. PubMed ID: 10830716 [TBL] [Abstract][Full Text] [Related]
18. In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery. Egilmez NK; Cuenca R; Yokota SJ; Sorgi F; Bankert RB Gene Ther; 1996 Jul; 3(7):607-14. PubMed ID: 8818648 [TBL] [Abstract][Full Text] [Related]
19. [Antitumor efficacy of the recombinant Newcastle disease virus rNDV-IL15 on melanoma models]. Niu ZS; Bai FL; Sun T; Tian H; Yin JC; Cao HW; Yu D; Tian GY; Wu YZ; Li DS; Ren GP Yao Xue Xue Bao; 2014 Mar; 49(3):310-5. PubMed ID: 24961100 [TBL] [Abstract][Full Text] [Related]
20. Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregates. Reimer DL; Kong S; Monck M; Wyles J; Tam P; Wasan EK; Bally MB J Pharmacol Exp Ther; 1999 May; 289(2):807-15. PubMed ID: 10215656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]